| Name: | Aripiprazole N,N-Dioxide |
| Catalogue No. | VE006781 |
| CAS No. | 573691-13-1 |
| Molecular Formula | C23H27Cl2N3O |
| Molecular Weight | 480.38 |
| Status | In-stock |
| IUPAC Name | 7-[4-[4-(2,3-Dichlorophenyl)-1,4-dioxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone |
| Synonyms | Aripiprazole N,N-Dioxide |
| Description | Aripiprazole N,N-Dioxide(CAS No: 573691-13-1)or 7-[4-[4-(2,3-Dichlorophenyl)-1,4-dioxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone. it is a class of atypical antipsychotics and second-generation which is used for the treatment of bipolar I disorder, major depressive disorder, and schizophrenia. |
| References | Minassian, Arpi, and Jared W. Young. “Evaluation of the Clinical Efficacy of Asenapine in Schizophrenia.” Expert Opinion on Pharmacotherapy, vol. 11, no. 12, July 2010, pp. 2107–15, https://doi.org/10.1517/14656566.2010.506188. |
![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/thumb_aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)
